Oncology

Hodgkin lymphoma cancer survivors are 2.4 times more likely to develop a second type of cancer.

Scientists identify specific genes that cooperate with a well-known tumor suppressor gene.

Genes can interact with a tumor suppressor gene to prevent the development of breast, prostate, and skin cancer.

Study identifies 2 immune system molecules that may play a key role in drug-resistance.

The cytokines interleukin 1 beta (IL1β) and tumor necrosis factor alpha (TNFα) help the spread of drug-resistant cancer.

Baby Boomer age group testing levels for hepatitis C virus remained very low.

Study identifies potential Achilles heel of kinase-driven cancers.

Majority of patients were free from local recurrence after 1 year of reirradiation with an advanced form of proton therapy.

Top news of the day from across the health care landscape.

Treatment with endostatin slowed the proliferation of resistant prostate cancer cells.

Epalrestat could prevent metastasis in patients with basal-like triple-negative breast cancer.

High consumption of isoflavones reduced all-cause mortality in patients with breast cancer by 21%.

Repurposed drugs may provide new therapies for cancer.

Isoflavone supplements may influence outcomes among patients with breast cancer.

Most models were cancer-free within 6 weeks of treatment with selenomab-drug conjugates.

Next-generation antibody treatments effectively deliver cytotoxic drugs to tumors.

Corticosteroids, chemotherapy, and immunotherapy may all be used to treat castration-resistant prostate cancer.

Top news of the week in oncology and cancer drug development.

Checkpoint inhibitors plus myeloid-derived suppressor cell inhibitors show promise as prostate cancer treatment.

Quiescent stem cells are dormant and are not impacted by cancer treatments.

The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival in patients with breast cancer.

The addition of abemaciclib to fulvestrant appeared to effectively improve progression-free survival.

New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.

High yogurt intake may protect against breast cancer, while processed cheeses may increase cancer risk.

Mapping lung cancer cell interactions can unveil new targeted treatment techniques.

Vitamin C observed to kill cancer stem-like cells.

Nanomachines produce a florescent response when in contact with cancer biomarkers.

Muscle composition may be predictive of chemotherapy toxicity.